Mr. Marcello Leone reports

FORTE GROUP ANNOUNCES AMENDED TERMS TO PREVIOUSLY ANNOUNCED WARRANT AMENDMENT

Further to the news release dated Oct. 10, 2025, which outlined an intention to amend the price and term of an aggregate of 1,152,937 common share purchase warrants aimed at strengthening Forte Group Holdings Inc.'s financial position, the company will amend the exercise price of the repriced warrants to 30 cents per share, effective Oct. 24, 2025, in accordance with Policy 6.7(6)(b) of the Canadian Securities Exchange.

All other terms and conditions of the repriced warrants, including, but not limited to, the requirement that the amendments be subject to the unanimous consent of the registered holders of the outstanding repriced warrants, together with the expiry date, acceleration provisions and all other elements disclosed in the initial disclosure, remain unchanged.

About Forte Group Holdings Inc.

Forte Group is a next-generation beverage and nutraceutical company focused on longevity and human performance. Through its Trace brand and private label partnerships, Forte Group develops and manufactures a portfolio of alkaline and mineral-enriched beverages and nutraceutical supplements. Headquartered in British Columbia, Canada, the company owns a pristine natural alkaline spring water aquifer and operates a 40,000-square-foot, Health Canada- and HACCP-certified manufacturing facility near Osoyoos, B.C. Forte Group delivers wellness-driven products through traditional retail and e-commerce channels, providing consumers with innovative solutions to support long-term vitality and well-being.

We seek Safe Harbor.